Prot #ARGX-113-2011: A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inf

Project: Research project

Project Details

StatusActive
Effective start/end date2/8/242/28/27

Funding

  • ICON Clinical Research, LLC (Prot #ARGX-113-2011 // Prot #ARGX-113-2011)
  • arGEN-X BV (Prot #ARGX-113-2011 // Prot #ARGX-113-2011)